Assessing The Sales Impact Of The New Health Insurance Exchange Market
Executive Summary
Many stakeholders have an interest in how the new health insurance exchanges mandated by the Affordable Care Act will impact product sales. While a multitude of known and unknown factors impact health insurance coverage decisions, and subsequently which services and products and services get used, surprisingly robust actuarial models used in the insurance industry are very applicable to forecasting product sales.
You may also be interested in...
Medicaid Expansion: Glass Half Full for Biopharma
Most health reform watchers have been tracking state votes on Medicaid expansion as a sort of scorecard on whether Obama Administration is winning or losing in health care reform. Push back from the states is making news now, but for biopharma sponsors, even a glass half full is a positive—and the long-term outlook is even brighter.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.